- Report
- February 2026
- 82 Pages
Global
From €3500EUR$3,980USD£3,016GBP
- Report
- January 2026
- 89 Pages
Global
From €3500EUR$3,980USD£3,016GBP
- Report
- November 2026
- 150 Pages
Global
From €4569EUR$4,850USD£3,804GBP
- Report
- October 2026
- 150 Pages
Global
From €4569EUR$4,850USD£3,804GBP
- Report
- October 2026
- 150 Pages
Global
From €4569EUR$4,850USD£3,804GBP
- Report
- October 2026
- 150 Pages
Global
From €4569EUR$4,850USD£3,804GBP
- Report
- November 2026
- 271 Pages
Global
From €6590EUR$6,995USD£5,487GBP
- Report
- September 2026
- 282 Pages
Global
From €2638EUR$2,800USD£2,196GBP
€3297EUR$3,500USD£2,745GBP
- Report
- May 2026
- 130 Pages
Global
From €4569EUR$4,850USD£3,804GBP
- Report
- February 2026
- 110 Pages
United States
From €2779EUR$2,950USD£2,314GBP
- Report
- July 2026
- 120 Pages
North America
From €4475EUR$4,750USD£3,726GBP
- Report
- July 2026
- 111 Pages
United States
From €4475EUR$4,750USD£3,726GBP
- Report
- December 2025
- 150 Pages
United States
From €4569EUR$4,850USD£3,804GBP
- Report
- January 2024
- 307 Pages
Global
From €5407EUR$5,940USD£4,350GBP
- Report
- December 2023
- 220 Pages
Global
From €4711EUR$5,000USD£3,922GBP
- Report
- August 2023
- 1500 Pages
Global
From €8244EUR$8,750USD£6,864GBP
- Report
- December 2022
- 211 Pages
Global
From €5653EUR$6,000USD£4,707GBP
- Report
- October 2022
- 348 Pages
Indonesia, Malaysia, Singapore Indonesia, Malaysia, Singapore
From €4711EUR$5,000USD£3,922GBP
- Report
- October 2022
- 220 Pages
United States
From €4711EUR$5,000USD£3,922GBP
- Report
- March 2022
- 312 Pages
Global
From €6595EUR$7,000USD£5,491GBP

The Liquid Biopsy market within the Pharmaceuticals industry is a rapidly growing field of research and development. It is a minimally invasive procedure that uses a sample of blood to detect and monitor cancer. It is used to detect cancer at an early stage, to monitor the progression of the disease, and to assess the effectiveness of treatments. Liquid biopsy can also be used to detect genetic mutations associated with cancer, which can help guide treatment decisions.
The Liquid Biopsy market is expected to grow significantly in the coming years due to its potential to improve patient outcomes and reduce healthcare costs. It is also expected to benefit from advances in technology, such as the development of more sensitive and specific tests.
Some companies in the Liquid Biopsy market include Guardant Health, Exact Sciences, Biocept, and Genomic Health. Show Less Read more